AstraZeneca has entered the “off-the-shelf” cell therapy space, penning a $1 billion deal to acquire EsoBiotec and its lentiviral vector platform. The deal will see AstraZeneca scoop up all ...

The UN Women report launched at COP28 projects that, by 2050, climate change could push up to 158 million more women and ...